Skip to content

Interest Expense at other companies

CTO
Citius Oncology, Inc.CTOR
$33.03K
Inhibrx Biosciences, Inc. logo
Inhibrx Biosciences, Inc.INBX
$3.51M+30.5%
ImmunityBio, Inc. logo
ImmunityBio, Inc.IBRX
$13.87M+2.5%
Avalo Therapeutics logo
Avalo TherapeuticsAVTX
$803K-30.1%
Vera Therapeutics logo
Vera TherapeuticsVERA
$1.82M+1.7%

Other financials

Income statement

See full
Revenue-
Net income-$7.5M-13.1%
EPS (diluted)-$0.13+13.3%

Balance sheet

See full
Cash & equivalents$6.3M+1.3%
Total debt$456.9K+178%
Total equity$23.2M+135%
Total assets$29.7M+103%

Cash flow

See full
Operating cash flow-$4.4M+6.9%
CapEx$48.8K+14.5%
Free cash flow-$4.5M+6.7%

Valuation

See full
Market cap$155.39M+45.8%
Enterprise value$149.54M+52.3%

Returns & leverage

See full
Return on equity-187.2%
Debt / equity0.0×
Current ratio1.2×-1.8×

Where this comes from

Reported directly by TuHURA Biosciences, Inc. in its filing.

Tagged under the XBRL concept us-gaap:InterestExpense.

The official record: TuHURA Biosciences, Inc.’s 10-Q, filed May 15, 2026, on SEC EDGAR. View the filing →

Ask your AI about TuHURA Biosciences, Inc.'s interest expense.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is TuHURA Biosciences, Inc.'s interest expense?
TuHURA Biosciences, Inc. (HURA) reported interest expense of $27.97K in Q1 2026.
What does interest expense mean?
Cost of borrowing — interest paid or accrued on bonds, bank loans, credit facilities, finance leases, and other debt obligations.